Are we ready for mutational directed treatment: addressing the genomic basis of myeloma
Gareth Morgan et al.
The stratification of CLL patients and implications for clinical practice
What is the role of inotuzumab ozogamicin in ALL
ABL001 – a new BCR-ABL inhibitor for chronic myeloid leukemia (CML) treatment
Expert advice for CLL patients: get treatment at specialized CLL centers